Analyst Rating Changes — Upgrades, Downgrades & Price Targets

52534 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Aug 13 00:18 UTC	MOBI Mobia Medical	◎ Target	JPMorgan Chase & Co.	Robbie Marcus ★★★☆☆ #1132	Overweight	$15.00→ $17.00+13.3%
Aug 13 00:18 UTC	MNPR Monopar Therapeutics	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2058	Buy	$117.00→ $133.00+13.7%
Aug 13 00:18 UTC	MLCO Melco Resorts & Entertainment	◎ Target	Susquehanna	Joseph Stauff ★★☆☆☆ #2644	Positive	$12.00→ $8.00-33.3%
Aug 13 00:18 UTC	MIDD Middleby	◎ Target	JPMorgan Chase & Co.	Tami Zakaria ★★★☆☆ #1354	Neutral	$151.00→ $141.00-6.6%
Aug 13 00:18 UTC	MFIC MidCap Financial Investment	◎ Target	Royal Bank Of Canada	Kenneth S. Lee not yet tracked	Sec→ r Perform	$11.00→ $10.00-9.1%
Aug 13 00:18 UTC	MDLN Medline	◎ Target	JPMorgan Chase & Co.	Lisa Gill ★★★☆☆ #1908	Overweight	$53.00→ $46.00-13.2%
Aug 13 00:18 UTC	MDB MongoDB	◎ Target	Oppenheimer	Ittai Kidron ★★★★★ #324	Outperform	$410.00→ $475.00+15.9%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Stifel Nicolaus	firm only	Buy	C$18.00→ C$21.00+16.7%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	Scotiabank	firm only	Sec→ r Outperform	C$19.00→ C$20.00+5.3%
Aug 13 00:18 UTC	MAU Montage Gold	◎ Target	ATB Cormark Capital Markets	firm only	Outperform	C$19.00→ C$22.00+15.8%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Stifel Nicolaus	Daniel Arias ★★★★☆ #777	Buy	$10.00→ $12.00+20.0%
Aug 13 00:18 UTC	MASS 908 Devices	◎ Target	Roth Capital	Max Masucci not yet tracked	Buy	$11.00→ $13.00+18.2%
Aug 13 00:18 UTC	MAA Mid-America Apartment Communities	◎ Target	Morgan Stanley	Adam Kramer ★★★☆☆ #1315	Overweight	$155.00→ $147.00-5.2%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	BTIG Research	Julian Harrison ★★☆☆☆ #2643	Buy	$109.00→ $111.00+1.8%
Aug 13 00:18 UTC	LQDA Liquidia	◎ Target	Needham & Company LLC	Serge Belanger ★★☆☆☆ #2399	Buy	$70.00→ $110.00+57.1%
Aug 13 00:18 UTC	LOW Lowe's Companies	◎ Target	Royal Bank Of Canada	Steven Shemesh ★★★☆☆ #1242	Sec→ r Perform	$232.00→ $231.00-0.4%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	TD Cowen	Sean O'Loughlin ★★★☆☆ #1992	Hold	$800.00→ $820.00+2.5%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	JPMorgan Chase & Co.	Joseph Cardoso ★★★★☆ #837	Overweight	$1,165.00→ $1,280.00+9.9%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Bank of America	Vivek Arya ★★☆☆☆ #2698	Neutral	$1,100.00→ $1,000.00-9.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Morgan Stanley	Meta Marshall ★★★☆☆ #1903	Equal Weight	$900.00→ $1,000.00+11.1%
Aug 13 00:18 UTC	LITE Lumentum	◎ Target	Mizuho	Vijay Rakesh ★★★☆☆ #2191	Outperform	$1,100.00→ $1,140.00+3.6%
Aug 13 00:18 UTC	LENZ LENZ Therapeutics	◎ Target	Piper Sandler	Biren Amin ★★☆☆☆ #2276	Neutral	$12.00→ $7.00-41.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Morgan Stanley	Matthew Harrison not yet tracked	Overweight	$48.00→ $49.00+2.1%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Royal Bank Of Canada	Leonid Timashev ★★★☆☆ #1572	Outperform	$59.00→ $58.00-1.7%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	TD Cowen	Yaron Werber ★★☆☆☆ #2303	Hold	$29.00→ $24.00-17.2%
Aug 13 00:18 UTC	LEGN Legend Biotech	◎ Target	Barclays	Etzer Darout ★★★★☆ #586	Overweight	$80.00→ $78.00-2.5%
Aug 13 00:18 UTC	LEG Leggett & Platt	◎ Target	Piper Sandler	Peter Keith ★★★☆☆ #1332	Neutral	$12.00→ $10.00-16.7%
Aug 13 00:18 UTC	LDOS Leidos	◎ Target	The Goldman Sachs Group	Gavin Parsons ★★★☆☆ #2026	Neutral	$152.00→ $132.00-13.2%
Aug 13 00:18 UTC	LBRX LB Pharmaceuticals	◎ Target	BMO Capital Markets	Malcolm Hoffman not yet tracked	Outperform	$46.00→ $54.00+17.4%
Aug 13 00:18 UTC	LAR Lithium Americas (Argentina)	◎ Target	Scotiabank	Ben Isaacson ★★☆☆☆ #2519	Sec→ r Outperform	$10.00→ $9.50-5.0%
Aug 13 00:18 UTC	LAMR Lamar Advertising	◎ Target	Wells Fargo & Company	Steven Cahall ★★★★☆ #617	Equal Weight	$150.00→ $151.00+0.7%
Aug 13 00:18 UTC	KSPI Joint Stock Company Kaspi.kz	◎ Target	Susquehanna	James Friedman ★★★☆☆ #2133	Neutral	$95.00→ $100.00+5.3%
Aug 13 00:18 UTC	KRNT Kornit Digital	◎ Target	Needham & Company LLC	James Ricchiuti ★★☆☆☆ #2558	Buy	$22.00→ $23.00+4.5%
Aug 13 00:18 UTC	KNTK Kinetik	◎ Target	Truist Financial	Gabe Daoud not yet tracked	Buy	$53.00→ $59.00+11.3%
Aug 13 00:18 UTC	JRVR James River Group	◎ Target	Truist Financial	Mark Hughes ★★★☆☆ #1707	Hold	$6.00→ $5.00-16.7%
Aug 13 00:18 UTC	JBS JBS	◎ Target	JPMorgan Chase & Co.	Lucas Ferreira ★★★★★ #164	Overweight	$18.00→ $17.50-2.8%
Aug 13 00:18 UTC	JBI Janus International Group	◎ Target	UBS Group	John Lovallo ★★★☆☆ #1725	Neutral	$6.00→ $5.60-6.7%
Aug 13 00:18 UTC	IPI Intrepid Potash	◎ Target	UBS Group	Joshua Spector ★★★☆☆ #2106	Sell	$26.00→ $29.00+11.5%
Aug 13 00:18 UTC	IPHA Innate Pharma	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2058	Buy	$8.00→ $9.00+12.5%
Aug 13 00:18 UTC	INTC Intel	◎ Target	UBS Group	Timothy Arcuri ★★★☆☆ #1958	Neutral	$121.00→ $112.00-7.4%
Aug 13 00:18 UTC	INF Informa	◎ Target	Citigroup	firm only	Buy	GBX 990→ GBX 1,090+10.1%
Aug 13 00:18 UTC	IMNM Immunome	◎ Target	Truist Financial	Supawat Thongthip not yet tracked	Buy	$37.00→ $38.00+2.7%
Aug 13 00:18 UTC	IMNM Immunome	◎ Target	Wedbush	David Nierengarten ★★★☆☆ #2236	Outperform	$31.00→ $35.00+12.9%
Aug 13 00:18 UTC	IAG Iamgold	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2469	Sec→ r Perform	$22.00→ $23.00+4.5%
Aug 13 00:18 UTC	HRB H&R Block	◎ Target	Barrington Research	Alexander Paris ★★☆☆☆ #2777	Outperform	$50.00→ $60.00+20.0%
Aug 13 00:18 UTC	HRB H&R Block	◎ Target	The Goldman Sachs Group	George Kelly ★☆☆☆☆ #3062	Sell	$29.00→ $33.00+13.8%
Aug 13 00:18 UTC	HPQ HP	◎ Target	The Goldman Sachs Group	Michael Ng not yet tracked	Sell	$19.00→ $21.00+10.5%
Aug 13 00:18 UTC	HMH HMH	◎ Target	Stifel Nicolaus	Stephen Gengaro ★★☆☆☆ #2288	Buy	$27.00→ $28.00+3.7%
Aug 13 00:18 UTC	HLIO Helios Technologies	◎ Target	Stifel Nicolaus	Nathan Jones ★★★☆☆ #1957	Buy	$93.00→ $95.00+2.2%
Aug 13 00:18 UTC	HLIO Helios Technologies	◎ Target	JPMorgan Chase & Co.	Tomohiko Sano ★★☆☆☆ #2606	Overweight	$100.00→ $110.00+10.0%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!